Closing Bell: Nervgen Pharma Corp up on Thursday (NGEN)

Today, Nervgen Pharma Corp shares closed at $2.98 after opening the day at $2.90. prices ranged from $2.89 to $2.99.

The price advanced 3.47 percent from the previous day's close of $2.88.

During the day across North America, the TSX Composite closed -1.68% at 22723.21, the S&P 500 closed 1.58% at 5522.30, the Dow Jones Industrial Average closed 0.24% at 40842.79 and the Nasdaq Composite closed 2.64% at 17599.40.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

Trading volume was 79,619 on 258 total trades, while having an average volume of 39,782 over 5 days.

The TSX-V market on the whole today saw 907 price advancers against 4,327 declines and 72 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 52 weeks, Nervgen Pharma Corp's shares have surged 76.33%, while they have gained 10.37% year-to-date.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $201.39 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..